SEC Tracker
Get the app

Acura Pharmaceuticals ACUR

Acura Pharmaceuticals secures $100K loan

Form
8-K
Filed
Importance
Routine
  1. Received $100,000 loan on Oct 2, 2026
  2. Total principal balance is $11,294,279 as of Sep 30, 2026
  3. Accrued interest of $1,365,000 as of Sep 30, 2026
  4. Interest rate is 5.25% on the note

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Acura Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Ayala Pharmaceuticals ADXS
  2. Ampio Pharmaceuticals AMPE
  3. Alterity Therapeutics ATHE
  4. Adhera Therapeutics ATRX
  5. Avricore Health AVCRF